Mixed cryoglobulinaemia associated with hepatitis C virus infection: A predictor factor for treatment with interferon?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 11, 1999, Pages 1108-1111

  Pellicano, Rinaldo ^a   Marietti, Giorgio ^b   Leone, Nicola ^a   Arena, Vincenzo ^a   Palmas, Franco ^a   Rizzetto, Mario ^a   Ponzetto, Antonio ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

Cryoglobulinaemia; Hepatitis C virus; Interferon

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032704093     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.02015.x     Document Type: Article

References (19)

1. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N. Engl. J. Med. 1992; 327: 1899-905.
2. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 1992; 327: 1490-5.
3. Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver disease: Role of hepatitis C virus and liver damage. Gastroenterology 1994; 106: 1291-300.
4. Davis GL, Lau JYN. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 1997; 26: S122-7.
5. Misiani R, Bellavita P, Fenili D et al. Interferon alfa 2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Engl. J. Med. 1994; 330: 751-6.
6. Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
7. Ishak K, Baptista A, Bianchi I. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995; 22: 696-9.
8. Pugh RNH, Murray-Lyon IM, Dawson JL et al. Transection of the esophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
9. Alter HJ. Clinical, virological and epidemiological basis for the treatment of chronic non-A, non-B hepatitis. J. Hepatol. 1990; 11: S19-25.
10. Nishioka K, Watanabe J, Furuta S et al. A high prevalence of the antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429-33.
11. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann. Int. Med. 1995; 123: 615-20.
12. Ferri C, La Civita L, Longobardo G, Greco F, Bombardieri S. Hepatitis C virus and mixed cryoglobulinemia. Eur. J. Clin. Invest. 1993; 23: 399-405.
13. Booth JCL, Brown JL, Thomas HC. The management of chronic hepatitis C virus infection. Gut 1995; 37: 449-454.
14. Carreño V, Marriott E, Quiroga JA. Other approaches to the treatment of chronic viral hepatitis. J. Hepatol. 1993; 17: S127-9.
15. Bellobuono A, Mondazzi L, Tempini S et al. Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C. A randomized clinical trial. J. Viral Hepatitis 1997; 4: 185-91.
16. Pingel S, Hartmann H, Ramadori G. Essential mixed cryoglobulinemia (EMC) in a case of chronic hepatitis C: Successful treatment with interferon alpha. Z. Gastroenterol. 1994; 32: 584-8.
17. Durand JM, Cretel E, Kaplanski G et al. Long-term results of therapy with interferon alpha for cryoglobulinemia associated with hepatitis C virus infection. Clin. Rheumatol. 1994; 13: 123-5.
18. Migliaresi S, Tirri G. Interferon in the treatment of mixed cryoglobulinemia. Clin. Exp. Rheumatol. 1995; 13: 175-80.
19. Mazzaro C, Carniello GS, Colle R et al. Interferon therapy in HCV-positive mixed cryoglobulinaemia: Viral and host factors contributing to efficacy of the therapy. Ital. J. Gastroenterol. Hepatol. 1997; 29: 343-50.